The European Technology Platform on Nanomedicine
White PaperNanomedicine Contribution
to Horizon 2020
Identification of European Nanomedicine Actors
ETP NanomedicineApply for Membership
- Featured News
Presentations and Webstreams of the Open Info Days on Challenge „Health, Demographic Change and Wellbeing“ available
The Open Info Days on Challenge „Health, Demographic Change and Wellbeing“ took place on 22.11.13 in Brussels.
6th Joint Call for European Research Projects on Rare Diseases (JTC 2014) (Innovative therapeutic approaches)
On the 5th of December 2013 E-Rare will officialy open its 6th Joint Transnational Call for Research Projects on Rare Diseases (JTC 2014). This year the call is specifically dedicated to development of innovative therapeutic approaches for rare diseases. The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach
3rd Joint Transnational Call for Proposals of the ERA-NET on Translational Cancer Research to be launched in December 2013
The ERA-NET on Translational Cancer Research (TRANSCAN) has been established with the ultimate goal of coordinating the research efforts and funding programmes of European countries in translational cancer research. In this line, TRANSCAN will launch the third Joint Transnational Call for research proposals (JTC) in December 2013.
The European Commission made public these documents just before the adoption process of the work programmes to provide potential participants with the currently expected main lines of the work programmes 2014-2015. However, they are working documents not yet endorsed by the Commission and their contents does not in any way prejudge the final decision of the Commission.
Smart Systems Integration in the LEIT ICT Work Programme 2014-2015
NANOFORCE is organising its 3rd "Nanodeal Event" on 12th December 2013 in Milan to present success stories, business opportunities offered through Nanotechnologies and experiences by private and public actors.
Organised by the British Society for Nanomedicine (BSNM), the first day is dedicated to the Integration of pharmacology and chemistry to maximise benefits and minimise risks for nanomedicine development
The ETP Nanomedicine and its partners organise the Nano World Cancer Day 2014 on 31st January. The objective of this pan-European event is to hold simultaneously several press conferences in different leading regions of Europe to emphasise the role of nanomedicine to fight cancer.